Felix Berlth

Appearances

THE IMPACT OF PATHOLOGICAL TUMOR RESPONSE FOLLOWING NEOADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR ESOPHAGEAL ADENOCARCINOMA. A RETROSPECTIVE MULTICENTER COHORT STUDY
Date
May 21, 2024
Two multimodal strategies are available for the treatment of esophageal cancer: neoadjuvant chemotherapy (nCT) and chemoradiotherapy (nCRT). The higher rate of pathological complete response (pCR) after nCRT is an argument to support this treatment…
Presenter
Giovanni Capovilla
Speakers
Alessia Scarton
Elisa Sciuto
Lucia Moletta
Elisa Sefora Pierobon
Gianpietro Zanchettin
Federica Riccio
Luca Provenzano
Renato Salvador
University of Padova
Felix Berlth
Evangelos Tagkalos
Eren Uzun
Carlo Alberto De Pasqual
Cecilia Turolo
Jacopo Weindelmayer
Simone Giacopuzzi
Giovanni De Manzoni
Peter Grimminger
Michele Valmasoni
Padova University Hospital - Center for Esophageal Diseases